Back to Search
CHERYL EMOTO, M.D.
M.D.
Pediatrics Physician
NPI: 1639267966Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
G55837(CA)
Research & Publications (16)
Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: Impact of plasma and microsomal binding.
PMID 19280521·Xenobiotica·2009
8-other
Effects of enzyme sources on midazolam 1'-hydroxylation activity catalyzed by recombinant cytochrome P450 3A4 in combination with NADPH-cytochrome P450 reductase.
PMID 19356092·Drug Metab Lett·2008
8-other
Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human.
PMID 11491388·Xenobiotica·2001
7-preclinical
Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes.
PMID 11315103·Xenobiotica·2000
7-preclinical
Use of everted sacs of mouse small intestine as enzyme sources for the study of drug oxidation activities in vitro.
PMID 11315105·Xenobiotica·2000
7-preclinical
Functional characterization of CYP3A4.16: catalytic activities toward midazolam and carbamazepine.
PMID 19255940·Xenobiotica·2009
7-preclinical
Non-invasive method to detect induction of CYP3A4 in chimeric mice with a humanized liver.
PMID 18274954·Xenobiotica·2008
7-preclinical
Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5.
PMID 18220568·Curr Drug Metab·2008
4-observational
Metabolism of CJ-036878, N-(3-phenethoxybenzyl)-4-hydroxybenzamide, in liver microsomes and recombinant cytochrome P450 enzymes: metabolite identification by LC-UV/MS(n) and (1)H-NMR.
PMID 18033636·Xenobiotica·2007
7-preclinical
CYP3A4 and CYP3A5 catalyse the conversion of the N-methyl-D-aspartate (NMDA) antagonist CJ-036878 to two novel dimers.
PMID 17943661·Xenobiotica·2007
8-other
Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes.
PMID 17896325·Xenobiotica·2007
4-observational
Relative roles of CYP2C19 and CYP3A4/5 in midazolam 1'-hydroxylation.
PMID 17614006·Xenobiotica·2007
8-other
Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage.
PMID 16891248·Xenobiotica·2006
8-other
In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A.
PMID 16272753·Drug Metab Pharmacokinet·2005
4-observational
In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole.
PMID 15618748·Drug Metab Pharmacokinet·2003
8-other
Causative agent of vascular pain among photodegradation products of dacarbazine.
PMID 12195827·J Pharm Pharmacol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16455 MAIN ST.
HESPERIA, CA 92345 - Phone
- (760) 947-2161
Quick Facts
- NPI
- 1639267966
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile